United States Interventional Cardiology Devices market to grow at a Significant Rate till 2026
Benefits of early diagnosis
of coronary artery diseases and demand for effective treatment is expected to
drive the United States interventional cardiology devices market for the
forecast period.
According to TechSci Research report, “United
States Interventional Cardiology Devices Market By Product Type
(Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters,
Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others) By
End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others) By
Company, By Region, Forecast & Opportunities, 2026”, The United States interventional
cardiology devices market is expected to witness significant growth for the
next five years. Heart related disease are considered the most serious health
condition and is responsible for leading to death of patients. Therefore, the
patients suffering from cardiovascular disease or those at high cardiovascular
risk require early detection and treatment of diseases. Use of high-resolution
technologies for example magnetic imaging resonance and computer tomography,
optical coherence tomography is effective in identifying the cardiovascular
disease during the first medical treatment procedure. Launch of novel products ensuring
high accuracy and efficiency resulting in fewer traumas to patient and ensure
quick recovery is expected to influence the market growth.
The COVID-19 outbreak across the world which has been
declared as pandemic by World Health Organization has affected countries
adversely. Leading authorities in United States imposed lockdown restrictions
and released a set of precautionary measures to contain the spread of novel
coronavirus. Coronavirus affected patients started suffering from shortness of
breath along with coughing and sneezing. United States authorities increased
the capacity of hospitals as a greater number of patients were getting affected
daily and getting admitted into the hospital facilities. Number of patients
visiting the hospital facilities for ailment other than coronavirus has
significantly reduced even though emergency and OPD services are available in
cardiology department. This has reduced the sales of interventional cardiology
devices market and thereby affected the market adversely.
However, availability of alternate products may create
hindrance in the growth of the interventional cardiology devices market.
Browse XX Figures spread
through XX Pages and an in-depth TOC on "United States Interventional
Cardiology Devices Market”.
https://www.techsciresearch.com/report/united-states-interventional-cardiology-devices-market/7516.html
United
States interventional cardiology devices market is segmented into type, end
user, regional distribution, and company. Based on product type, market can be
further divided into angioplasty balloons, angioplasty stents, structural heart
devices, catheters, plaque modification devices, hemodynamic flow alteration
devices, and others. The hemodynamic flow alteration device is fragmented into
embolic protection devices and chronic total occlusion devices. The embolic
protection devices are in high demand due to advantages of these devices over
chronic total occlusion devices for example the ability to capture the embryo
debris without disturbing the continuous blood flow. The catheters segment is
expected to register fastest incremental growth during the forecast period. The
benefits offered by catheters such as occurrence of minimal complications,
lower contrast agent usage and reduced haemostasis which are the significant
factors contributing to high demand for catheters segment. Catheters in
interventional cardiology are also cost-effective in nature over its other
counterparts and ensure the patient safety along with the facility for faster
patient mobilization.
Medtronic
USA, Inc., Boston Scientific Corporation, Abbott Laboratories, Inc., Biotronik,
Inc., Edwards LifeSciences Corporation, Cardinal Health, Inc., B. Braun Medical
Inc., Terumo Americas Holding Inc., Cordis Corporation, Cook Medical Inc., are the
leading players operating in United States interventional cardiology devices
market. Manufacturers are increasingly focusing on research and development
process to fuel higher growth in the market. To meet evolving customer demand
with respect to better efficiency and durability, several interventional
cardiology devices manufacturers are coming up with their technologically
advanced offerings.
Download
Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7516
Customers can also
request for 10% free customization on this report.
“Growing
adoption of advanced cardiovascular treatments and introduction of
technologically advanced treatment is boosting the demand for interventional
cardiology devices market. Rise in preference for minimally invasive surgeries
due to faster recovery, minimal hospital stay and cost-effective nature over
the traditional methods which require more invasive procedures such as coronary
artery bypass surgery. Drug eluting stents are in high demand which are
minimally invasive treatment procedure are coated with medication and released
into the body without affecting the flow of the blood. These also reduces the
need for repetitive angioplasty procedures to prevent the risk of heart pain
and stroke. Favorable government intitaives for product development in addition
with high patient awareness is expected to propel the growth of the
interventional cardiology devices market until 2026” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“United States
Interventional Cardiology Devices Market By Product Type (Angioplasty Balloons,
Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification
Devices, Hemodynamic Flow Alteration Devices, Others) By End User (Hospitals
& Clinics, Ambulatory Surgery Centers, Others) By Company, By Region,
Forecast & Opportunities, 2026” has
evaluated the future growth potential of United States interventional
cardiology devices market and provided statistics & information on market
size, shares, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in the of United
States interventional cardiology devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Web:
https://www.techsciresearch.com/